Glutathione and the response of malignant cells to chemotherapy

Drug Discovery Today

Volumn 3, Issue 3, 1998, Pages 113-121

  Kearns, Pamela R ^a   Hall, Andrew G ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CARBOPLATIN; CARMUSTINE; CISPLATIN; CYCLOSPORIN A; ETACRYNIC ACID; ETOPOSIDE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; INDOMETACIN; MULTIDRUG RESISTANCE PROTEIN; VERAPAMIL; VINCRISTINE;

APOPTOSIS; CANCER CELL; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CELL DEATH; CLINICAL TRIAL; DRUG CYTOTOXICITY; DRUG RESISTANCE; DRUG SYNTHESIS; HOMEOSTASIS; HUMAN; MITOCHONDRION; NONHUMAN; REVIEW;

EID: 0032030765     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(97)01156-2     Document Type: Review

References (84)

1. 1 Fahey, R.C. and Sundquist, A.R. (1991) Adv. Enzymol. 64, 1-53
2. 2 Tew, K.D. (1994) Cancer Res. 54, 4313-4320
3. 3 Meister, A. (1995) Meth. Enzymol. 251, 3-7
4. 4 Thomas, M., Nicklee, T. and Hedley, D.W. (1995) Br. J. Cancer 72, 45-50
5. 5 Jevtovic-Todorovic, V. and Guenthner, T.M. (1992) Biochem. Pharmacol. 44, 1383-1393
6. 6 Mårtensson, J., Lai, J.C.K. and Meister, A. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 7185-7189
7. 7 Cossarizza, A. et al. (1995) Exp. Cell Res. 220, 232-240
8. 8 Kroemer, G. et al. (1995) FASEB J. 9, 1277-1287
9. 9 Macho, A. et al. (1997) J. Immunol. 158, 4612-4619
10. 10 Marchetti, P. et al. (1997) Eur. J. Immunol. 27, 289-296
11. 11 Meister, A. (1995) Meth. Enzymol. 252, 26-30
12. 12 Gulick, A.M. and Fahl, W.E. (1995) Pharmacol. Ther. 66, 237-257
13. 13 Commandeur, J.N.M., Stijntjes, G.J. and Vermeulen, N.P.E. (1995) Pharmacol. Rev. 47, 271-330
14. 14 Campbell, J.A.H. et al. (1991) Cancer 67, 1608-1613
15. 15 Pemble, S. et al. (1994) Biochem. J. 300, 271-276
16. 16 Zhong, S. et al. (1993) Carcinogenesis 14, 1821-1824
17. 17 Nakajima, T. et al. (1995) Carcinogenesis 16, 707-711
18. 18 Evans, C.G. et al. (1987) Cancer Res. 47, 2525-2530
19. 19 Smith, M.T. et al. (1989) Cancer Res. 49, 2621-2625
20. 20 Tsuchida, S. and Sato, K. (1992) Crit. Rev. Biochem. Mol. Biol. 27, 337-384
21. 21 Chen, G. and Waxman, D.J. (1995) Biochem. Pharmacol. 49, 1691-1701
22. 22 O'Brien, M.L. and Tew, K.D. (1996) Eur. J. Cancer 32, 907-978
23. 23 Lewis, A.D. et al. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 8511-8515
24. 24 Batist, G. et al. (1986) J. Biol. Chem. 261, 15544-15549
25. 25 Lewis, A.D., Hayes, J.D. and Wolf, C.R. (1988) Carcinogenesis 9, 1283-1287
26. 26 Hall, A.G. et al. (1994) Cancer Res. 54, 5251-5254
27. 27 Malik, I.A. et al. (1997) Cancer Chemother. Pharmacol. 39, 561-565
28. 28 Miyazaki, M. et al. (1990) Biochem. Biophys. Res. Commun. 166, 1358-1364
29. 29 Leyland Jones, B.R. et al. (1991) Cancer Res. 51, 587-594
30. 30 Hall, A. et al. (1989) Cancer Res. 49, 6265-6268
31. 31 Ciaccio, P.J., Tew, K.D. and LaCreta, F.P. (1991) Biochem. Pharmacol. 42, 1504-1507
32. 32 Tew, K.D., Bomber, A.M. and Hoffman, S.J. (1988) Cancer Res. 48, 3622-3625
33. 33 Clapper, M.L., O'Dwyer, P.J. and Tew, K.D. (1990) in Glutathione S-Transferases and Drug Resistance (Hayes, J.D., Pickett, C.B. and Mantle, T.J., eds), pp. 451-459, Taylor and Francis
34. 34 O'Dwyer, P.J. et al. (1991) Cancer Res. 51, 6059-6065
35. 35 Ji, X. et al. (1992) Biochemistry 31, 10169-10184
36. 36 Rushmore, T.H. and Pickett, C.B. (1993) J. Biol. Chem. 268, 11475-11478
37. 37 Koehler, R.T. et al. (1997) Proteins 28, 202-216
38. 38 Schultz, M., Dutta, S. and Tew, K.D. (1997) Adv. Drug Deliv. Rev. 26, 91-104
39. 39 Flatgaard, J.E., Bauer, K.E. and Kauvar, L.M. (1993) Cancer Chemother. Pharmacol. 33, 63-70
40. 40 Morgan, A.S. et al. (1996) Cancer Chemother. Pharmacol. 37, 363-370
41. 41 Dulik, D.M., Fenselau, C. and Hilton, J. (1986) Biochem. Pharmacol. 35, 3405-3409
42. 42 Hall, A.G. et al. (1994) Cancer Res. 54, 3369-3372
43. 43 Jakoby, W. B. (1978) Adv. Enzymol. 46, 383-414
44. 44 Meyer, D.J. et al. (1992) Br. J. Cancer 66, 433-438
45. 45 Dreyfus, F. et al. (1995) Bone Marrow Transplant. 15, 707-711
46. 46 Seitz, D.E., Winter, M.A. and Pearce, H.L. (1989) Cancer Res. 30, 497
47. 47 Chen, G. and Waxman, D.J. (1994) Biochem. Pharmacol. 47, 1079-1087
48. 48 Medh, R.D., Gupta, V. and Awasthi, Y.C. (1991) Biochem. Pharmacol. 42, 439-441
49. 49 Meijer, C. et al. (1990) Br J. Cancer 62, 72-77
50. 50 Mistry, P. et al. (1991) Br. J. Cancer 64, 215-220
51. 51 Kisara, S. et al. (1995) Oncol. Res. 7, 191-200
52. 52 Ferrari, G., Van, C.Y. and Greene, L.A. (1995) J. Neurosci. 15, 2857-2866
53. 53 Ozols, R.F. et al. (1987) Biochem. Pharmacol. 36, 147-153
54. 54 O'Dwyer, P.J. et al. (1992) J. Natl. Cancer Inst. 84, 264-270
55. 55 Bailey, H.H. et al. (1994) J. Clin. Oncol. 12, 194-205
56. 56 Beaver, J.P. and Waring, P. (1995) Eur. J. Cell Biol. 68, 47-54
57. 57 Maung, Z.T. et al. (1994) Leukemia 8, 1487-1491
58. 58 Jedlitschky, G. et al. (1996) Cancer Res. 56, 988-994
59. 59 Loe, D.W., Deeley, R.G. and Cole, S.P.C. (1996) Eur. J. Cancer 32, 945-957
60. 60 Hussey, A.J. and Hayes, J.D. (1992) Biochem. J. 286, 929-935
61. 61 Zaman, G.J.R. et al. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 7690-7694
62. 62 Versantvoort, C.H. et al. (1995) Br. J. Cancer 72, 82-89
63. 63 Paul, S. et al. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 6929-6934
64. 64 Feller, N. et al. (1995) FEBS Lett. 368, 385-388
65. 65 Hickman, J.A. (1996) Eur. J. Cancer 32, 921-926
66. 66 Payne, C.M., Bernstein, C. and Bernstein, H. (1995) Leuk. Lymphoma 19, 43-93
67. 67 Burdon, R.H. et al. (1996) Free Radic. Res. 24, 81-93
68. 68 Slater, A.F.G. et al. (1995) Toxicol. Lett. 82-3, 149-153
69. 69 Um, H.D., Orenstein, J.M. and Wahl, S.M. (1996) J. Immunol. 156, 3469-3477
70. 70 Iwata, S. et al. (1997) J. Immunol. 158, 3108-3117
71. 71 Hockenbery, D.M. et al. (1993) Cell 75, 241-251
72. 72 Packham, G., Ashmun, R.A. and Cleveland, J.L. (1996) J. Immunol. 156, 2792-2800
73. 73 Ghibelli, L. et al. (1995) Biochem. Biophys. Res. Commun. 216, 313-320
74. 74 Beaver, J.P. and Waring, P. (1995) Eur. J. Cell Biol. 68, 47-54
75. 75 Jacobson, M.D. and Raff, M.C. (1995) Nature 374, 814-816
76. 76 Slater, A.F.G. et al. (1996) Cell Death Differ. 3, 57-62
77. 77 Vandendobbelsteen, D.J. et al. (1996) J. Biol. Chem. 271, 15420-15427
78. 78 Kroemer, G. (1997) Nat. Med. 3, 614-620
79. 79 Nehmé, A. et al. (1995) Int. J. Cancer 61, 643-648
80. 80 Lin, K.I. et al. (1995) J. Cell Biol. 131, 1149-1161
81. 81 Meyer, M., Schreck, R. and Baeuerle, P.A. (1993) EMBO J. 12, 2005-2015
82. 82 Pognonec, P., Kato, H. and Roeder, R.G. (1992) J. Biol. Chem. 267, 24563-24567
83. 83 Abate, C. et al. (1990) Science 249, 1157-1161
84. 84 Droge, W. et al. (1994) FASEB J. 8, 1131-1139